|
11:00 - 12:00 |
|
Registration and Refreshments |
|
12:00 - 13:30 |
|
Networking Buffet Lunch in the Exhibition Hall |
|
13.30 - 13:45 |
|
Welcome and Opening Remarks |
|
13.45 |
SESSION 1: INHALED THERAPY IN SPECIAL POPULATIONS |
|
|
13:45 - 14.15 |
|
Inhaled Therapy for Small Children, are our Current Inhalation Devices Suitable for Them? – Summary of the Morning Symposium |
|
14:15 - 14:45 |
|
Advances in Aerosol Delivery in Intubated and Non-intubated Critically Ill Patients |
|
14:45 - 15:15 |
|
Matching Delivery Device to a Patient’s Condition: The use of Lung Deposition Modelling to Optimise Delivery in IPF Sandy Munro, Vectura Ltd |
|
15:15 - 16:45 |
|
Exhibition, Posters and Refreshments |
|
16:45 - 17:00 |
|
How to make a Standard Inhaler Device into a ‘Smart’ Inhaler that Teaches Technique Mark Sanders, Clement Clarke International Limited |
|
17:00 - 17:15 |
|
A comparison of Aerosol Delivery across two High Flow Therapy interfaces: Nasal Cannula and Tracheostomy Tube |
|
17:15 - 17:30 |
|
A Comparison of Different Anatomical Throats vs The USP Throat Samantha Holmes, 3M Drug Delivery Systems Division |
|
17.30 |
|
DDL EMERGING SCIENTIST LECTURE The presenter of this lecture was chosen as the DDL Emerging Scientist for 2017. This award recognises significant scientific accomplishment or innovation during the early stages of an individual’s career in inhalation science. For more information about the award please click here.
|
|
18:00 - 20:00 |
|
Exhibitor Drinks Reception Drinks and Canapes for all attendees Sponsored by Vectura |
|
07:30 - 08:40 |
|
Registration and Refreshments Exhibition Hall & Poster Viewing |
|
08:40 - 08:45 |
Opening of Conference |
|
|
08:45 - 09:30 |
|
ANNUAL DDL LECTURE Looking Back and Looking Ahead: Developments in Aerosol Medicine over the last 50 years – Devices, Drugs and Detection of Disease |
|
09:30 - 10:10 |
|
EMA Update on Quality Guidelines on Inhalation and Nasal Products |
|
10:10 - 11:15 |
|
Exhibition, Posters and Refreshments |
|
11:15 |
SESSION 2: EMERGING THERAPEUTICS AND NOVEL RESPIRATORY MEDICINES
|
|
|
11:15 - 11:45 |
|
Nanoparticulate systems for respiratory delivery |
|
11:45 - 12:15 |
|
Where have all the Inhaled Biologics gone?
|
|
12:15 - 12:30 |
|
Chondroitin Sulphate Microparticles as Antitubercular Drug Carriers Susana Rodrigues, University of Algarve |
|
12:30 - 12:45 |
|
Hybrid Nano-in-Micro Systems for Lung Delivery of Host Defence Peptides (HDP) using as Adjunct Therapeutics for Pulmonary TB Rahul K Verma, Institute of Nano Science and Technology (Government of India) |
|
12:45 - 14:00 |
|
Networking Buffet Lunch Exhibition Hall and Poster Viewing |
|
14:00 |
SESSION 3: THE PAT BURNELL NEW INVESTIGATOR AWARD
|
|
|
14:00 - 14:15 |
|
Further studies on the Drug Deposition Mechanisms of Surface-treated pMDI Canisters Athina Skemperi, University of Loughborough |
|
14:15 - 14:30 |
|
Loading, Release and Activity of Inhalable Benzothiazinone-Loaded Human Albumin Nanocarriers for Anti-tuberculosis Therapy Ayasha Patel, King’s College London |
|
14:30 - 14:45 |
Cocrystal Approach to Reduce the Aqueous Solubility and Dissolution Rate for Improved Residence Time of an Anti-tubercular Drug in the Lungs Basanth Babu Eedara, University of Otago |
|
|
14:45 - 15:00 |
|
Identification of Contaminants on Lactose using Ultrasound Acoustic-AFM. Impact on the Interactions Drug-carrier Cedric Thomas, Université Bourgogne Franche-Comté |
|
15:00 - 15:15 |
|
Characterisation of a Nasal Spray for Nose to Brain Delivery of Insulin in Human Volunteers Jed Wingrove, King’s College London |
|
15:15 - 15:30 |
|
Pulmonary Dry Powders containing a Vaccine against Human Papillomavirus Irene Rossi, University of Parma |
|
15:30 - 16:30 |
|
Exhibition, Posters and Refreshments |
|
16:30 |
SESSION 4: INHALATION DEVICES AND AEROSOL SCIENCE |
|
|
16:30 - 17:00 |
|
Understanding what Happens to Aerosols on Inhalation: Dynamics of Size and Compositional Change Jonathan Reid, University of Bristol
|
|
17:00 - 17:15 |
|
Simulation of the Dose from a Dry Powder Inhaler Kyrre Thalberg, AstraZeneca
|
|
17:15 - 17:30 |
|
What Can the Pharmaceutical Industry Learn from E-Cigarettes? Simon Smith and Joanne Channon, Cambridge Consultants |
|
17:30 - 18:00 |
|
Vaping Liquids: A Formulator’s Dream? |
|
18:00 - 19:00 |
AWARDS CEREMONY INCLUDING:
Join us for a celebratory drink to honour these achievements |
|
08:30 - 09:30 |
|
Registration and Refreshments Exhibition Hall and Poster Viewing |
|
09:30 |
SESSION 5: MODELLING AND SIMULATIONS IN INHALATION SCIENCE |
|
|
09:30 - 10:00 |
|
Model Informed Development of Dry Powder Inhaler (DPI) Formulation and Processes |
|
10:00 - 10:30 |
|
In silico Clinical Trials of Regional Lung Deposition: How they could Impact Real Life Product Development and Patient Care |
|
10:30 - 11:45 |
|
Posters, Exhibition & Refreshments |
|
11:45 - 12:15 |
|
Lung-Sim: A Physiologically Based Biopharmaceutical Prediction Tool Ulrika Tehler, IMED |
|
12:15 - 12:30 |
|
Improved Protocol for Relating Impactor Stage Pressure Drop to the Suitability for Routine Use Daryl L. Roberts, Applied Particle Principles, LLC |
|
12:30 - 12:45 |
|
Acoustic Emission combined with Multivariate Data Analysis as a Tool for Characterisation of Formulations for Inhalation Lars Karlsson, AstraZeneca R&D |
|
12:45- 13:00 |
|
Concluding Remarks and Conference Close |
To download the event poster list, please use the button below.
Event Poster list
